Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance. [electronic resource]
Producer: 20080116Description: 30-5 p. digitalISSN:- 1935-5548
- Adamantane -- analogs & derivatives
- Blood Glucose -- drug effects
- C-Peptide -- blood
- Dipeptidyl-Peptidase IV Inhibitors -- therapeutic use
- Double-Blind Method
- Female
- Gastric Inhibitory Polypeptide -- blood
- Glucagon -- blood
- Glucagon-Like Peptide 1 -- blood
- Glucose Intolerance -- drug therapy
- Humans
- Inulin -- blood
- Kinetics
- Male
- Nitriles -- therapeutic use
- Placebos
- Postprandial Period
- Pyrrolidines -- therapeutic use
- Vildagliptin
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.